Malaysian Genomics Resource Centre Bhd (XKLS:0155) Long-Term Capital Lease Obligation : RM1.42 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Long-Term Capital Lease Obligation?

Malaysian Genomics Resource Centre Bhd's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was RM1.42 Mil.

Malaysian Genomics Resource Centre Bhd's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (RM1.70 Mil) to Mar. 2024 (RM1.52 Mil) and declined from Mar. 2024 (RM1.52 Mil) to Jun. 2024 (RM1.42 Mil).

Malaysian Genomics Resource Centre Bhd's annual Long-Term Capital Lease Obligation stayed the same from Jun. 2019 (RM0.00 Mil) to Jun. 2020 (RM0.00 Mil) but then increased from Jun. 2020 (RM0.00 Mil) to Jun. 2021 (RM1.30 Mil).

Malaysian Genomics Resource Centre Bhd Long-Term Capital Lease Obligation Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Long-Term Capital Lease Obligation Chart

Malaysian Genomics Resource Centre Bhd Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.09

1.30

Malaysian Genomics Resource Centre Bhd Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24	Jun24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.07	0.97	1.70	1.52	1.42

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Malaysian Genomics Resource Centre Bhd Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Malaysian Genomics Resource Centre Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810

Website

http://www.mgrc.com.my

Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd Headlines

No Headlines